192 Results

People

  1. Mandelker
    Mandelker
  2. Offit
    Offit
  3. Robson
    Robson
  4. Stadler
    Stadler
  5. Berger
    Berger
  6. Walsh
    Walsh
  7. Joseph
    Joseph
  8. Ladanyi
    Ladanyi
  9. Carlo
    Carlo
  10. Kemel
    Kemel

Groups

  1. Department of Medicine (122)
  2. Solid Tumor Oncology Division (114)
  3. GSK Faculty (79)
  4. Department of Pathology and Laboratory Medicine (74)
  5. Population Sciences Research Program (74)
  6. Survivorship Research (66)
  7. Surgery (50)
  8. Center for Pancreatic Cancer Research (49)
  9. Clinical Genetics Service (48)
  10. Tow Center for Developmental Oncology (TCDO) (46)
  1. "germline mutation"
Formats
  1. Journal Article (141)
  2. Review (29)
  3. Editorial (11)
  4. Guidelines (4)
  5. Correspondence (3)
  6. Research Letter (2)
  7. Conference Paper (1)
  8. Meeting Abstract (1)
Groups
  1. Department of Medicine (122)
  2. Solid Tumor Oncology Division (114)
  3. GSK Faculty (79)
  4. Department of Pathology and Laboratory Medicine (74)
  5. Population Sciences Research Program (74)
  6. Survivorship Research (66)

More Groups

People
  1. Diana Mandelker (30)
  2. Kenneth Offit (30)
  3. Zsofia Stadler (29)
  4. Mark Robson (27)
  5. Michael Walsh (22)
  6. Michael Berger (19)

More People

Years
  1. 2025 (12)
  2. 2024 (38)
  3. 2023 (30)
  4. 2022 (15)
  5. 2021 (2)
  6. 2020 (31)

More Years

Publications
  1. Clinical Cancer Research (10)
  2. Gynecologic Oncology (10)
  3. JCO Precision Oncology (10)
  4. Journal of Clinical Oncology (7)
  5. Journal of Thoracic Oncology (6)
  6. Annals of Oncology (5)

More Publications

Publishers
  1. Elsevier Inc. (31)
  2. Nature Publishing Group (20)
  3. American Society of Clinical Oncology (17)
  4. American Association for Cancer Research (15)
  5. Oxford University Press (14)
  6. Springer (11)

More Publishers

Results (192)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice
    Guidelines

    Westphalen, C. B.; Boscolo Bielo, L.; Aftimos, P.; Beltran, H.; Benary, M.; Chakravarty, D.; Collienne, M.; Dienstmann, R.; El Helali, A.; Gainor, J.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Germline pathogenic variants in DNA repair pathways: A key feature in a significant subset of translocation-associated sarcomas
    Journal Article

    Saoud, C.; Dermawan, J. K.; Arora, K.; Tap, W. D.; Reed, D.; Slotkin, E. K.; Wexler, L. H.; Murciano-Goroff, Y. R.; Latham, A.; Mandelker, D. L.; more...
    npj Precision Oncology (2025)

    Fulltext@MSK | Save
  • Pathogenic germline variants among women with uterine cancer by ancestry: A commercial laboratory collaborative research registry study
    Journal Article

    Johnson, C. R.; Aryasomayajula, C.; Francoeur, A. A.; Stewart, C.; Sia, T. Y.; Darcy, K. M.; Tian, C.; Kapp, D. S.; Liu, Y. L.; Chan, J. K.
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Update on retinoblastoma predisposition and surveillance recommendations for children
    Review

    Kamihara, J.; Schienda, J.; McGee, R. B.; Friedman, D. N.; Rednam, S. P.; Brzezinski, J. J.; Kim, S. Y.; Becktell, K. D.; Lupo, P. J.; Gallie, B. L.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • The influence of the germline HSD3B1 adrenal-permissive allele (c.1100 C) on the somatic alteration landscape, the transcriptome, and immune cell infiltration in prostate cancer
    Journal Article

    Kellen, S.; Makovec, A.; Miller, C. D.; Nazari, S. S.; Elliott, A.; Deacon, A.; John, E.; Vobugari, N.; Agarwal, N.; McKay, R. R.; more...
    Cancers (2025)

    Fulltext@MSK | Save
  • Glioma grade and mortality in relation to sequence variation in the mitochondrial genome
    Journal Article

    Peeri, N. C.; Teer, J. K.; Thompson, Z. J.; Nabors, L. B.; Brooks, M.; Sologon, C. M.; Williams, S. L.; Egan, K. M.
    Cancer Genetics (2025)

    Fulltext@MSK | Save
  • Expert consensus on treating HR+/HER2-metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists
    Journal Article

    Rugo, H. S.; Bardia, A.; Gradishar, W. J.; Hamilton, E. P.; Hurvitz, S. A.; Jhaveri, K.; Mahtani, R.; Tolaney, S. M.
    Breast (2025)

    Fulltext@MSK | Save
  • Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer
    Journal Article

    Zucker, M.; Perry, M. A.; Gould, S. I.; Elkrief, A.; Safonov, A.; Thummalapalli, R.; Mehine, M.; Chakravarty, D.; Brannon, A. R.; Ladanyi, M.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • Management of patients with advanced prostate cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
    Journal Article

    Gillessen, S.; Turco, F.; Davis, I. D.; Efstathiou, J. A.; Fizazi, K.; James, N. D.; Shore, N.; Small, E.; Smith, M.; Sweeney, C. J.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Germline DNA damage repair variants and prognosis of patients with high-risk or metastatic prostate cancer
    Journal Article

    Stopsack, K. H.; Vijai, J.; Conry, M.; Berchuck, J. E.; Kemel, Y.; Vasselman, S. E.; Freeman, D. A.; Lee, G. S. M.; Mandelker, D.; Solit, D. B.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save